Correlation Between Swedish Orphan and Dr Reddys

Can any of the company-specific risk be diversified away by investing in both Swedish Orphan and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swedish Orphan and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Swedish Orphan Biovitrum and Dr Reddys Laboratories, you can compare the effects of market volatilities on Swedish Orphan and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swedish Orphan with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swedish Orphan and Dr Reddys.

Diversification Opportunities for Swedish Orphan and Dr Reddys

0.23

Correlation Coefficient

Swedish Orphan  Dr Reddys

Modest diversification

The 3 months correlation between Swedish and RDDA is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Swedish Orphan Biovitrum and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Swedish Orphan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swedish Orphan Biovitrum are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Swedish Orphan i.e., Swedish Orphan and Dr Reddys go up and down completely randomly.

Pair Corralation between Swedish Orphan and Dr Reddys

Assuming the 90 days horizon Swedish Orphan is expected to generate 1.19 times less return on investment than Dr Reddys. But when comparing it to its historical volatility, Swedish Orphan Biovitrum is 1.2 times less risky than Dr Reddys. It trades about 0.24 of its potential returns per unit of risk. Dr Reddys Laboratories is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  1,330  in Dr Reddys Laboratories on September 22, 2024 and sell it today you would earn a total of  100.00  from holding Dr Reddys Laboratories or generate 7.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.65%
Values	Daily Returns

Swedish Orphan Biovitrum  vs.  Dr Reddys Laboratories

Swedish Orphan Biovitrum

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Swedish Orphan Biovitrum has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Swedish Orphan is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Dr Reddys Laboratories

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Swedish Orphan and Dr Reddys

The main advantage of trading using opposite Swedish Orphan and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swedish Orphan position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.

The idea behind Swedish Orphan Biovitrum and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.